Fusion Pharmaceuticals to Present at the Guggenheim Securities Radiopharmaceuticals Day

HAMILTON, ON and BOSTON, May 11, 2022 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in a fireside chat at…